SOPHiA DDM™ for KAPA HyperExome is a fully integrated bioinformatic workflow (FASTQ to Report), designed to streamline your variant analysis, interpretation and reporting. From data to insights and ultimately to confident care, SOPHiA DDM™ for KAPA HyperExome will save you time, maximize your sequencing output and increase confidence in your results.
SOPHiA DDM™ enables real-time SARS-CoV-2 surveillance, enabling the detection of new and emerging strains with high accuracy and confidence. Join this exclusive webinar and discover how the platform accelerates SARS-CoV-2 analyses.
The latest SOPHiA publication about SARS-CoV-2 surveillance
As we continue to advance the analyses of SARS-CoV-2, our experts have identified an important and novel mutational hotspot. Read how the SOPHiA DDM™ platform is fundamental to better understand the variants that “escape” immunity.
“ We come from all over the world, from different backgrounds, we don’t speak the same language and don’t have the same culture, but we all learn from one another and grow together, united by the same exceptional company mission.”
The information included in this document has been prepared for and is intended for viewing by a global audience. This document contains information about products and services which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indication for use. Please consult local sales representative.
Sign Up To Our Newsletter
Join our mailing list to receive the latest news and updates from SOPHiA GENETICS.